Shanxi C&Y Pharmaceutical Hits Day Low at CNY 8.06 Amid Price Pressure

Shanxi C&Y Pharmaceutical Group Co., Ltd. has experienced significant volatility today, with the stock hitting an intraday low of CNY 8.06, reflecting a decline of 12.49%. This performance starkly contrasts with the broader market, as the China Shanghai Composite index fell by only 3.05% during the same period. Over the past week, Shanxi C&Y's stock has decreased by 1.33%, while its monthly performance shows a decline of 9.67%. Year-to-date, the stock has dropped 19.66%, and over the past year, it has seen a substantial decrease of 29.43%. In comparison, the China Shanghai Composite has gained 7.03% over the last year. Financial metrics indicate challenges for the company, including a low Return on Capital Employed (ROCE) of 2.56% and a net profit of CNY 3.34 million, which has fallen by 61.31%. The company's long-term growth appears limited, with net sales declining at an annual rate of 1.20%. Despite being net-debt free, the stock's valuation remains high with a Price to Book ratio of 2.84, and a Return on Equity (ROE) of 12.47%.